Medications
FDA approves new drug for inhaled anthrax
Federal health officials say they approved a new injectable drug from Human Genome Sciences to treat inhalable anthrax.
Dec 14, 2012
0
0
News tagged with glaxosmithkline
Other
GSK unveils expansion plans in India, Nigeria
British drugmaker GlaxoSmithKline said it intends to increase its holdings in its Indian and Nigerian divisions, as part of a long-term strategy to expand into emerging markets, in a statement on Monday.
Nov 26, 2012
0
0
Medications
1990s trial gave early danger signs for asthma drugs
The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results.
Nov 25, 2012
0
0
Other
GlaxoSmithKline says Q3 net profits drop 18.5%
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profits fell 18.5 percent from a year earlier to £1.12 billion ($1.80 billion, 1.39 billion euros), hit by weak conditions in Europe.
Nov 1, 2012
0
0
Inflammatory disorders
Severe allergic asthma linked to gene variation
(Medical Xpress)—A new study from the University of Alberta shows that your genes could be the reason your allergic asthma or hay fever is so severe.
Oct 15, 2012
0
0
Oncology & Cancer
New drug shrinks brain tumours in melanoma patients
(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.
Oct 8, 2012
0
0
Cardiology
Blood tests for inflammation could help prevent heart attack, stroke
(HealthDay)—Among people at high risk for cardiovascular disease, knowing their blood levels of two specific markers for inflammation might help prevent a heart attack or stroke, according to British investigators.
Oct 4, 2012
0
0
Medications
US says Teva antidepressant is ineffective
(AP)—Teva Pharmaceuticals has stopped shipping its generic version of a popular antidepressant off the market after a U.S. government analysis showed the pill does not work properly.
Oct 3, 2012
0
0
Oncology & Cancer
Combination of targeted treatment drugs delays resistance in melanoma patients
Combined treatment with two drugs targeting different points in the same growth-factor pathway delayed the development of treatment resistance in patients with BRAF-positive metastatic malignant melanoma. The results of a ...
Sep 29, 2012
0
0
Medications
Public Citizen: State drug fraud cases on the rise
(AP)—A consumer advocacy group is reporting that pharmaceutical companies have paid more than $30 billion to state and federal governments to settle allegations of fraud over the last 20 years.
Sep 27, 2012
0
0
